Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. LGND
10. INNV

Go back to Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®

Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMA

April 6, 2016 12:35 PM EDT

Pfizer (NYSE: PFE) is adding to early gains after terminating the deal to acquire Allergan and shares just crossed about its 200 day moving average on high volume. Shares last traded up 3.7% to $32.53.

... More